Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Concord Healthcare Group CoHKSE:02453 -1.39%30 EBIT per Share is HK$-0.28 as of Dec. 2025. GuruFocus rates HKSE:02453 with a GF Score™ of 30/100. The stock has 6 warning signs investors should review. Among 525 Healthcare Providers & Services companies, Concord Healthcare Group Co ranks better than 65.71% on this metric.
Concord Healthcare Group Co's EBIT per Share for the
six
months ended in Dec. 2025 was HK$-0.07.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.28.
During the past 3 years, the average EBIT per Share Growth Rate was 23.10% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 5.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Concord Healthcare Group Co's EBIT per Share or its related term are showing as below:
HKSE:02453'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -7.8 Med: 1.9 Max: 23.1
Current: 23.1
During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Concord Healthcare Group Co was 23.10% per year. The lowest was -7.80% per year. And the median was 1.90% per year.
HKSE:02453's 3-Year EBIT Growth Rate is ranked better than 65.71% of 525
companies
in the Healthcare Providers & Services industry
Industry Median: 12
vs HKSE:02453: 23.10
Concord Healthcare Group Co (HKSE:02453) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Concord Healthcare Group Co EBIT per Share Related Terms
Concord Healthcare Group Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.28
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Concord Healthcare Group Co (HKSE:02453) has a EBIT per Share of HK$-0.28 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Concord Healthcare Group Co and its competitors. According to the industry distribution chart, Concord Healthcare Group Co ranks #180 out of 525 companies in the Healthcare Providers & Services industry, placing it in the top 34.3%.
Is Concord Healthcare Group Co's EBIT per Share too high?
Concord Healthcare Group Co's current EBIT per Share is HK$-0.28. Based on the distribution chart, Concord Healthcare Group Co ranks #180 out of 525 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Concord Healthcare Group Co has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Concord Healthcare Group Co's EBIT per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Concord Healthcare Group Co ranks #180 out of 525 companies for EBIT per Share. This puts Concord Healthcare Group Co in the upper half of its industry. The industry median EBIT per Share is 12.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.00, based on 525 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Concord Healthcare Group Co and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Concord Healthcare Group Co's current EBIT per Share is HK$-0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Healthcare Group Co stock overvalued right now?
Concord Healthcare Group Co (HKSE:02453) has a current EBIT per Share of HK$-0.28. The current EBIT per Share is HK$-0.28. Concord Healthcare Group Co's overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Concord Healthcare Group Co (HKSE:02453), the current EBIT per Share is HK$-0.28 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The Group owns and operates four offline self-operated medical institutions and one medical institution under construction, dedicated to providing comprehensive and specialized medical services to cancer patients. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is generated from its hospital business and its medical equipment, software, and related services segment. Substantially all of the company's revenue is generated from the PRC.
30GF Score
Get the complete analysis for HKSE:02453
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02453 has been successfully added to your 
